RecruitingNot Applicable

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

France500 participantsStarted 2024-02-22

Plain-language summary

Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult female (≥ 18 years old) * Patient treated at a hospital between February 1, 2024 and February 28, 2024 * Having undergone cardiotocography in the labor and delivery room * Gestational age at delivery \>36 weeks Exclusion Criteria: * Patient who has expressed opposition to the use of medical record data * Patient without CTG * Gestational age at delivery \<36 weeks

What they're measuring

Percentage of signal loss during fetal heart rate (FHR) recording during labor.

Timeframe: during labor

Trial details

NCT IDNCT06906744

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-22

Contact for this trial

Georges-Emmanuel ROTH, Midwife

33.3.69.55.35.46 georges-emmanuel.roth@chru-strasbourg.fr

View on ClinicalTrials.gov More Maternal Heart Rate trials